CSO Pharma Baltic - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 458,010 | 340,031 | 361,990 | 311,406 | 312,708 | 420,311 | 328,261 | - |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -3,380 | -49,404 | 5,854 | 9,775 | -19,130 | -7,868 | 7,322 | -19,204 |
| Equity | 101,565 | 52,160 | 58,014 | 67,789 | 48,659 | 40,791 | 48,163 | 39,734 |
| Liabilities | 23,680 | 22,546 | 15,328 | 23,356 | 33,912 | 21,120 | 23,845 | 2,517 |
| Non-current assets | 11,577 | 5,528 | 1,026 | 418 | 12,083 | 8,175 | 4,404 | 634 |
| Current assets | 124,967 | 73,175 | 71,395 | 92,419 | 70,397 | 55,752 | 70,187 | 41,781 |
| Total assets | 136,544 | 78,703 | 72,421 | 92,837 | 82,480 | 63,927 | 74,591 | 42,415 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 33,564 | 16,667 | 2,379 |
| Social insurance contributions | - | - | - | - | - | 22,982 | 7,405 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +6.1% | -25.8% | +6.5% | -14.0% | +0.4% | +34.4% | -21.9% | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.5% | -62.8% | 8.1% | 10.5% | -23.2% | -12.3% | 9.8% | -45.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3.3% | -94.7% | 10.1% | 14.4% | -39.3% | -19.3% | 15.2% | -48.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.7% | -14.5% | 1.6% | 3.1% | -6.1% | -1.9% | 2.2% | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.4 | 0.3 | 0.3 | 0.7 | 0.5 | 0.5 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,952 | 26,325 | 32,908 | 31,402 | 34,113 | 52,539 | 65,652 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
CSO Pharma Baltic - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-26 | 2026-07-29 | 117.04 |
| 2026-07-23 | 2026-07-25 | 117.59 |
| 2026-07-19 | 2026-07-22 | 117.04 |
| 2026-07-16 | 2026-07-17 | 117.04 |
| 2026-06-16 | 2026-07-15 | 46.73 |
| 2025-08-19 | 2025-08-29 | 95.02 |
| 2025-07-16 | 2025-08-18 | 24.71 |
| 2025-03-18 | 2025-03-23 | 24.24 |
| 2025-02-18 | 2025-02-19 | 33.93 |
| 2025-01-16 | 2025-01-20 | 2053.75 |
| 2024-10-01 | 2024-10-01 | 255.86 |
| 2024-09-17 | 2024-09-30 | 608.66 |
| 2024-08-19 | 2024-08-19 | 820.53 |
| 2024-07-16 | 2024-07-16 | 1327.59 |
| 2024-06-18 | 2024-06-18 | 1132.36 |
| 2024-04-16 | 2024-04-17 | 1127.65 |
| 2024-01-16 | 2024-01-18 | 1884.80 |
| 2023-12-18 | 2023-12-20 | 1756.40 |
| 2023-08-17 | 2023-08-17 | 1595.30 |
| 2023-07-18 | 2023-07-18 | 1542.86 |
| 2023-03-16 | 2023-03-19 | 2215.20 |
| 2022-12-16 | 2022-12-18 | 2001.05 |
CSO Pharma Baltic - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-11-28 | 2024-11-29 | 337.26 |
| 2024-10-03 | 2024-10-09 | 156.75 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.